Stephen Michael Kelsey

See Remarks

Stephen Michael Kelsey (See Remarks) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $18.7M of RVMD (92,531 sh across 8 lots, as filed), executed Sep 11.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$22.5M

shares × price, as filed

Last traded

Sep 16

Filed Sep 18

Median ADV $548.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $30.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

RVMD

Revolution Medicines, Inc. RVMD · 0 buys · 13 sells 13 filings

Recent filings

RVMDSALE Revolution Medicines, Inc. View filing → $171K
4,289 sh × $39.83
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $129K
3,294 sh × $39.04
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $212K
4,663 sh × $45.40
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $978K
16,666 sh across 2 lots
Exec Nov 13 2024
Filed Nov 15 2024 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $825K
16,666 sh across 2 lots
Exec Oct 14 2024
Filed Oct 16 2024 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $206K
4,665 sh × $44.19
Exec Sep 16 2024
Filed Sep 18 2024 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $722K
16,667 sh across 2 lots
Exec Sep 13 2024
Filed Sep 16 2024 · 5:30 PM ET